BioArctic AB published the company’s second quarter report for April – June 2022 on Tuesday, July 12, 2022, at 08:00 a.m. CET.
Halting the disease progression would lead to great benefits to patients, families and caregivers.
The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.
BioArctic is committed to help people with neurodegenerative disorders
